Get the Stockscreener App
1.26
1.56%
-0.02
After Hours:
1.25
-0.01
-0.79%
Hoth Therapeutics Inc Stock (HOTH) Forecast
The Hoth Therapeutics Inc (HOTH) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $35.62, representing a +2,727% increase from the current price of $1.26. The highest analyst price target is $61.79, and the lowest is $9.4623.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month HOTH Price Target
Average 35.62
(+2,727% Upside)
Is Hoth Therapeutics Inc (HOTH) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.89 | Neutral |
| STOCH(9,6) | 11.25 | Buy |
| STOCHRSI(14) | 4.83 | Buy |
| MACD(12,26) | 0.0624 | Sell |
| ADX(14) | 43.58 | Buy |
| William %R | -92.86 | Buy |
| CCI(14) | -42.32 | Neutral |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.34
Sell
|
1.3265
Sell
|
| MA20 |
1.4187
Sell
|
1.305
Sell
|
| MA50 |
1.0568
Buy
|
1.1482
Buy
|
| MA100 |
0.9796
Buy
|
1.0446
Buy
|
| MA200 |
0.9686
Buy
|
1.0426
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, HOTH could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 5 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on HOTH, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 49.89 indicates that HOTH is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 11.25 indicates that HOTH is oversold. This indicates that HOTH price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.83 indicates that HOTH is oversold. This suggests that HOTH price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 43.58 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -42.32 indicates that HOTH is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term HOTH price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Hoth Therapeutics Inc financial reports and earnings history, Hoth Therapeutics Inc (HOTH) stock could reach $138.50 by 2030, $92.57 by 2040 and $297.27 by 2050. See the projected annual prices until 2050 of the Hoth Therapeutics Inc stock below:
- Hoth Therapeutics Inc (HOTH) is expected to reach an average price of $27.47 in 2035, with a high prediction of $31.07 and a low estimate of $27.55. This indicates an $2,080% rise from the last recorded price of $1.26.
- Hoth Therapeutics Inc (HOTH) stock is projected to chart a bullish course in 2040, with an average price target of $88.88, representing an $6,954% surge from its current level. The forecast ranges from a conservative $89.09 to a sky-high $92.57.
- Our analysts predict Hoth Therapeutics Inc (HOTH) to jump 13,694% by 2045, soaring from $174.61 to an average price of $173.80, potentially reaching $177.53. While $174.61 is the low estimate, the potential upside is significant.
- Hoth Therapeutics Inc (HOTH) stock is expected to climb by 2050, reaching an average of $289.51, a $22,877% jump from its current level. However, a wide range of estimates exists, with high and low targets of $297.27 and $293.25, respectively, highlighting the market's uncertainty.
Hoth Therapeutics Inc Stock (HOTH) Year by Year Forecast
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2025
Hoth Therapeutics Inc Stock (HOTH) is expected to reach an average price of $32.22 in 2025, with a high prediction of $61.79 and a low estimate of $2.6486. This indicates an +2,457% rise from the last recorded price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $12.44 | $9.4623 | $61.79 | +887.38% |
| April, 2025 | $38.44 | $22.81 | $59.60 | +2,950% |
| May, 2025 | $35.06 | $40.31 | $33.31 | +2,683% |
| June, 2025 | $13.19 | $26.33 | $20.88 | +946.65% |
| July, 2025 | $43.35 | $40.79 | $39.85 | +3,340% |
| August, 2025 | $42.48 | $45.41 | $42.45 | +3,271% |
| September, 2025 | $36.10 | $36.29 | $32.85 | +2,765% |
| October, 2025 | $45.01 | $39.48 | $37.70 | +3,473% |
| November, 2025 | $51.64 | $46.58 | $50.39 | +3,999% |
| December, 2025 | $56.80 | $54.21 | $51.17 | +4,408% |
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2026
The predicted value for Hoth Therapeutics Inc (HOTH) in 2026 is set at an average of $41.90. Estimates vary from a peak of $52.96 to a trough of $30.84, indicating an +3,226% surge from the present price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $54.43 | $55.40 | $52.78 | +4,220% |
| February, 2026 | $53.31 | $53.81 | $52.96 | +4,131% |
| March, 2026 | $37.93 | $41.90 | $47.34 | +2,911% |
| April, 2026 | $27.09 | $30.84 | $34.03 | +2,050% |
| May, 2026 | $33.47 | $37.97 | $34.44 | +2,556% |
| June, 2026 | $42.35 | $37.75 | $35.78 | +3,261% |
| July, 2026 | $50.51 | $48.63 | $48.24 | +3,908% |
| August, 2026 | $42.88 | $44.38 | $46.60 | +3,304% |
| September, 2026 | $43.79 | $42.26 | $41.29 | +3,376% |
| October, 2026 | $45.92 | $45.36 | $44.39 | +3,545% |
| November, 2026 | $42.55 | $46.05 | $45.61 | +3,277% |
| December, 2026 | $44.46 | $43.36 | $43.21 | +3,428% |
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Hoth Therapeutics Inc (HOTH) is $44.60, with a high forecast of $50.15 and a low forecast of $39.05. This indicates an +3,440% increase from the last price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $45.09 | $44.21 | $43.77 | +3,478% |
| February, 2027 | $49.34 | $44.90 | $44.37 | +3,816% |
| March, 2027 | $49.62 | $49.28 | $48.29 | +3,838% |
| April, 2027 | $46.00 | $46.21 | $48.65 | +3,551% |
| May, 2027 | $48.59 | $50.03 | $50.15 | +3,757% |
| June, 2027 | $47.16 | $47.78 | $47.95 | +3,643% |
| July, 2027 | $42.86 | $44.16 | $42.76 | +3,302% |
| August, 2027 | $42.72 | $42.59 | $41.96 | +3,290% |
| September, 2027 | $44.89 | $45.07 | $44.04 | +3,463% |
| October, 2027 | $44.58 | $44.39 | $43.74 | +3,438% |
| November, 2027 | $42.05 | $42.43 | $41.95 | +3,238% |
| December, 2027 | $38.55 | $39.05 | $40.33 | +2,960% |
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2028
In 2028, Hoth Therapeutics Inc (HOTH) is projected to reach an average price of $30.51, with a high projection of $38.34 and a low estimate of $22.67. This indicates an +2,321% rise from the last price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $37.26 | $37.49 | $37.15 | +2,857% |
| February, 2028 | $37.42 | $37.42 | $36.63 | +2,870% |
| March, 2028 | $38.18 | $36.85 | $36.25 | +2,930% |
| April, 2028 | $37.92 | $38.44 | $38.34 | +2,909% |
| May, 2028 | $36.31 | $36.94 | $37.08 | +2,781% |
| June, 2028 | $32.08 | $32.05 | $31.27 | +2,446% |
| July, 2028 | $32.88 | $31.49 | $31.53 | +2,510% |
| August, 2028 | $31.05 | $31.14 | $31.60 | +2,364% |
| September, 2028 | $29.60 | $29.66 | $30.34 | +2,249% |
| October, 2028 | $28.06 | $28.11 | $28.97 | +2,127% |
| November, 2028 | $25.54 | $25.85 | $27.55 | +1,927% |
| December, 2028 | $22.52 | $22.67 | $23.17 | +1,688% |
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2029
The 2029 price forecast for Hoth Therapeutics Inc Stock (HOTH) is $69.05 on average, with a high prediction of $137.62 and a low estimate of $0.478. This represents an +5,380% increase from the previous price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $20.57 | $20.58 | $21.95 | +1,533% |
| February, 2029 | $19.04 | $19.05 | $20.06 | +1,411% |
| March, 2029 | $17.60 | $17.78 | $18.50 | +1,297% |
| April, 2029 | $16.18 | $16.20 | $17.12 | +1,184% |
| May, 2029 | $14.11 | $14.12 | $15.64 | +1,020% |
| June, 2029 | $12.19 | $12.27 | $13.52 | +867.56% |
| July, 2029 | $10.04 | $10.18 | $11.49 | +696.73% |
| August, 2029 | $7.7781 | $7.8081 | $9.5106 | +517.31% |
| September, 2029 | $5.9706 | $6.0056 | $7.3042 | +373.85% |
| October, 2029 | $3.4249 | $3.7749 | $5.4574 | +171.82% |
| November, 2029 | $1.8569 | $1.9024 | $2.8568 | +47.37% |
| December, 2029 | $137.62 | $0.478 | $137.62 | +10,822% |
Hoth Therapeutics Inc Stock (HOTH) Price Forecast for 2030
Hoth Therapeutics Inc Stock (HOTH) is expected to reach an average price of $127.57 in 2030, with a high forecast of $152.34 and a low forecast of $102.79. This signifies an +10,024% surge from the last price of $1.26.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $109.19 | $115.64 | $138.50 | +8,566% |
| February, 2030 | $138.44 | $142.25 | $123.63 | +10,888% |
| March, 2030 | $129.95 | $132.70 | $130.78 | +10,213% |
| April, 2030 | $119.45 | $138.64 | $123.83 | +9,380% |
| May, 2030 | $146.85 | $141.77 | $144.52 | +11,555% |
| June, 2030 | $152.28 | $152.34 | $142.65 | +11,985% |
| July, 2030 | $132.60 | $143.28 | $152.34 | +10,423% |
| August, 2030 | $109.60 | $137.22 | $129.29 | +8,598% |
| September, 2030 | $112.86 | $102.79 | $100.16 | +8,857% |
| October, 2030 | $116.42 | $121.80 | $110.11 | +9,140% |
| November, 2030 | $139.68 | $137.49 | $127.80 | +10,986% |
| December, 2030 | $153.18 | $159.12 | $144.12 | +12,058% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):